|
CASE STUDY (E)
Client-Partner - early stage start-up company
Product - device to percutaneously treat mitral valve disorders
Project -
European CE Marking clinical study
Number of Sites - initially four sites planned
Countries -
Italy, Germany and UK
Psephos services - introduction to potential investigators
- co-development of study documents
- relevant Ethics Committee submission and Approval
- Competent Authority notifications and agreement
Please close this window after reading to return to the main site
|
|